Advocacy

Protecting the Integrated Model of Care

High-quality, integrated care delivered in the independent medical practice setting is worthy of protection as an alternative to care that is often more costly when furnished in the hospital setting. Read more...

Saving the In Office Ancillary Service Exception (IOASE)

Integrated models of care allow for better coordination across specialties, translating into higher quality, lower cost and more accessible care for patients. Read more...

Pathology Services Utilization

Recent data, including 2009-2013 Medicare data relating to the cost and utilization of anatomic pathology (AP) services, demonstrates that the GAO report fails to tell the full story about cost and utilization. Read more...

Recent Advocacy

February 15, 2021

Policy Recommendations on Health Equity and Data Collection (APIAHF Health Brief)

This policy brief from the Asian & Pacific Islander American Health Forum provides a series of policy recommendations to address health inequities through legislation, regulatory changes, or policy guidance at both the state and federal level.
Continue Reading >>

January 28, 2021

DHPA Urges CMS to Rescind Ill-Conceived MFN Interim Final Rule

In a comment letter to the U.S. Centers for Medicare and Medicaid (CMS) regarding the Most Favored Nation (MFN) Interim Final Rule, DHPA wrote that the procedurally, statutorily and constitutionally flawed policy will severely restrict access to life-saving drug treatments and have adverse economic consequences for the Medicare program by shifting care from the more […]
Continue Reading >>

January 15, 2021

Implicit Bias Training (Kirwan Institute, Ohio State University)

This course will introduce you to insights about how our minds operate and help you understand the origins of implicit associations. You will also uncover some of your own biases and learn strategies for addressing them.
Continue Reading >>

November 30, 2020

DHPA Opposes Most Favored Nation Rule Announced by CMS

The MFN Rule could dramatically restrict patient access to infusion medications administered in physician offices, especially for patients with Crohn’s disease and ulcerative colitis, which are both major categories of inflammatory bowel disease (IBD).
Continue Reading >>

November 2, 2020

DHPA Supports USPSTF Recommendations to Begin CRC Screening at 45, Calls for More Research on Disparities in Communities of Color

While supporting the draft recommendations overall, Dr. Glenn Littenberg, DHPA chair of health policy, expressed some concern about USPSTF’s recommendations with respect to screening colonoscopy versus stool-based CRC screening.
Continue Reading >>